Acquisition of FSSolutions marks continued growth of Vault’s remote diagnostics platform
June 21, 2021 – Vault Health, Inc. (Vault) today announced the acquisition of FSSolutions, a leading workforce and employment screening company. The sale marks the continued growth of Vault’s remote diagnostics platform, which has already delivered virtual testing and specialized healthcare to millions of Americans.
“As Vault continues to grow, we remain focused on our mission to make better health outcomes more accessible and affordable to everyone,” said Jason Feldman, CEO and co-founder of Vault. “This includes employers, for whom occupational health and testing is a large and important part of their operations. FSS brings exciting new capabilities to our healthcare platform and the ability to perform background screening and other employment services to companies across the country.”
Since beginning as a men’s health company in 2018, Vault has become a leading provider of at-home and point-of-care healthcare solutions, including COVID-19 testing, large-scale COVID vaccinations, and decentralized clinical trials. With more than 650 government and educational contracts, and 2,500 enterprise customers, Vault has built a reputation as a leading virtual platform for telemedicine and diagnostics, addressing the consumer health, public health, life sciences, and now, occupational health markets.
FSS joins Vault with more than 30 years of experience in drug and alcohol testing programs and workforce employment screening, across a wide variety of industries, including healthcare, government, staffing, and transportation.
“The entire team at FSS has been so energized by this step,” said FSS President Michael Koffler. “Vault’s commitment to outstanding customer service, safety, and privacy aligns perfectly with our own values. We’re excited to be part of this growing healthcare company, one that has been such an integral part of our country’s COVID-19 response, and we look forward to the new opportunities this will provide for our existing and future clients.”
As of June 2021, Vault has administered nearly 7 million COVID-19 tests across the country and more than 350,000 vaccines. It is operating vaccination sites in many states, including New York City’s Empire State Building and Times Square, and continues to expand its at-home testing program through a number of state partnerships.
The acquisition brings Vault’s employee headcount to more than 500, with a network of more than 1,200 clinicians across all 50 states.
“Vault’s growth and success is due in large part to the talented and dedicated individuals we employ,” said Feldman. “They are key to our work of reimagining the 21st century healthcare experience for patients, practitioners, and providers, bringing specialty care and remote diagnostics to patients in their homes, on their home screens, and within their hometown communities – wherever they choose.”
About Vault Health
Vault is a leading virtual-first healthcare platform that specializes in delivering remote diagnostics and specialty care to consumers directly, through their employers, and through their local public health agencies. Vault also leverages its virtual platform to facilitate decentralized clinical trials for companies in the Pharmaceutical and Biotech industries. Vault is a leading provider of at-home FDA-approved COVID-19 testing in the U.S., whose solution has been deployed to numerous local and state governments, airlines, universities, professional athletic teams, companies, and organizations. Today, Vault employs more than 500 employees across the country and expects to continue growing as we expand our products and services.
